Search

Your search keyword '"BACHORZEWSKA-GAJEWSKA, HANNA"' showing total 154 results
Start Over Author "BACHORZEWSKA-GAJEWSKA, HANNA"
154 results on '"BACHORZEWSKA-GAJEWSKA, HANNA"'

14. Safety and Feasibility of a Novel Dosing Regimen of Tirofiban Administered in Patients with Acute Myocardial Infarction with ST Elevation Before Primary Coronary Angioplasty: A Pilot Study

Author

Kochman, Waclaw, Dobrzycki, Slawomir, Nowak, Konrad S., Chlopicki, Stefan, Kralisz, Pawel, Prokopczuk, Przemyslaw, Bachorzewska-Gajewska, Hanna, Gugala, Kamil, Maciej_Niewada, Mezynski, Grzegorz, Poniatowski, Bogdan, Korecki, Janusz, and Musial, Wlodzimierz J.

Published
2004
Full Text
View/download PDF

20. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals

Author

Dobrzycki, Slawomir, Kralisz, Pawel, Nowak, Konrad, Prokopczuk, Przemysław, Kochman, Waclaw, Korecki, Janusz, Poniatowski, Boguslaw, Zuk, Jerzy, Sitniewska, Ewa, Bachorzewska-Gajewska, Hanna, Sienkiewicz, Jerzy, and Musial, Wlodzimierz J

Published
2007

24. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery – a 867 Patient Study

Author

Tomaszuk-Kazberuk, Anna, primary, Nikas, Dimitrios, additional, Lopatowska, Paulina, additional, Młodawska, Elzbieta, additional, Malyszko, Jolanta, additional, Bachorzewska-Gajewska, Hanna, additional, Dobrzycki, Slawomir, additional, Sobkowicz, Bożena, additional, and Goudevenos, Ioannis, additional

Published
2018
Full Text
View/download PDF

25. Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients

Author

Mlodawska, Elzbieta, primary, Tomaszuk-Kazberuk, Anna, additional, Lopatowska, Paulina, additional, Waszkiewicz, Ewa, additional, Bachorzewska-Gajewska, Hanna, additional, Malyszko, Jolanta, additional, Michniewicz, Ewelina, additional, Dobrzycki, Slawomir, additional, and Musial, Wlodzimierz Jerzy, additional

Published
2016
Full Text
View/download PDF

26. Disturbances of Glucose Metabolism in Men Referred for Coronary Arteriography

Author

KOWALSKA, IRINA, PROKOP, JOLANTA, BACHORZEWSKA-GAJEWSKA, HANNA, TELEJKO, BEATA, KINALSKAL, IDA, KOCHMAN, WACLAW, and MUSIAL, WLODZIMIERZ

Subjects
Diabetes -- Research, Glucose metabolism -- Abnormalities, Atherosclerosis -- Risk factors, Health, Risk factors, Abnormalities
Abstract

IRINA KOWALSKA, MD [1] JOLANTA PROKOP, MD [2] HANNA BACHORZEWSKA-GAJEWSKA, MD [2] BEATA TELEJKO, MD [1] IDA KINALSKAL, MD [1] WACLAW KOCHMAN, MD [3] WLODZIMIERZ MUSIAL, MD [2] Postload glycemia [...]

Published
2001

33. Does Neutrophil Gelatinase-Asociated Lipocalin Have Prognostic Value in Patients with Stable Angina Undergoing Elective PCI? A 3-Year Follow-Up Study

Author

Bachorzewska-Gajewska, Hanna, primary, Tomaszuk-Kazberuk, Anna, additional, Jarocka, Iwona, additional, Mlodawska, Elzbieta, additional, Lopatowska, Paulina, additional, Zalewska-Adamiec, Malgorzata, additional, Dobrzycki, Slawomir, additional, Musial, Wlodzimierz J., additional, and Malyszko, Jolanta, additional

Published
2013
Full Text
View/download PDF

34. Do CHA2DS2VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.

Author

Lopatowska, Paulina, Tomaszuk‐Kazberuk, Anna, Mlodawska, Elzbieta, Bachorzewska‐Gajewska, Hanna, Malyszko, Jolanta, Dobrzycki, Slawomir, and Musial, Wlodzimierz J.

Abstract

Introduction Although recommendations for the antithrombotic management of atrial fibrillation (AF) are based on strong evidence, the European guidelines are not fully implemented into practice. Objectives The objective of this study is to analyse antithrombotic treatment in AF in Poland after the publication of the European Society of Cardiology Guidelines in 2012. Patients and Methods We retrospectively studied 1556 patients with AF from the Reference Cardiology University Centre in Poland in 2012-2014. Results CHA2DS2VASc and HAS-BLED scores were 3.5 ± 1.7 and 2.4 ± 1.1. Anti-vitamin K agent were prescribed in 59%, with non-vitamin K antagonist oral anticoagulants in 12%, acetylsalicylic acid (ASA) alone in 18%. Older patients ( p < 0.0001) and with paroxysmal AF were less likely to receive oral anticoagulation (OAC, p < 0.0001). The risk of stroke according to CHA2DS2VASc score was higher in patients who did not receive OAC ( p < 0.0001). The use of OAC increased with increasing CHA2DS2VASc score but was less frequent in score ≥ 4. The risk of bleeding was higher in patients without OAC ( p < 0.0001). The odds of non-vitamin K antagonist oral anticoagulants use were lower for older patients, patients with ischaemic heart disease, chronic heart failure, anaemia, HAS-BLED ≥ 3 and valvular AF. ASA was given in 39% of the patients, especially in paroxysmal AF ( p < 0.0001). The odds of ASA alone were higher for older patients, with ischaemic heart disease and history of myocardial infarction ( p < 0.0001). The odds of use of ASA as the only treatment were 5.5 times higher for HAS-BLED ≥ 3 ( p < 0.0001). Conclusions Antithrombotic management in AF is well implemented in Polish conditions, but we show the lack of pattern concerning who is being treated with OAC and ASA when it comes to the risk of stroke and bleeding. Copyright © 2015 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

44. Lack of ST-Segment Depression Normalization After PCI is a Predictor of 5-Year Mortality in Patients With ST-Elevation Myocardial Infarction

Author

Kozuch, Marcin, primary, Dobrzycki, Slawomir, additional, Nowak, Konrad, additional, Prokopczuk, Przemyslaw, additional, Kralisz, Pawel, additional, Bachorzewska-Gajewska, Hanna, additional, Kaminski, Karol, additional, Kozieradzka, Anna, additional, Korecki, Janusz, additional, Poniatowski, Boguslaw, additional, and Musial, Wlodzimierz Jerzy, additional

Published
2007
Full Text
View/download PDF

45. Chronic kidney disease in patients with significant left main coronary artery disease qualified for coronary artery bypass graft operation.

Author

Zalewska-Adamiec, Malgorzata, Bachorzewska-Gajewska, Hanna, Malyszko, Jolanta, Malyszko, Jacek S., Kralisz, Pawel, Tomaszuk-Kazberuk, Anna, Hirnle, Tomasz, and Dobrzycki, Slawomir

Subjects
*CHRONIC kidney failure, *GLOMERULAR filtration rate, *CORONARY artery bypass, *DISEASE prevalence, *DISEASE complications
Abstract

The article discusses a study which examines the prevalence of chronic kidney disease in patients with left main disease (LMD). The patients were divided into two groups according to estimated glomerular filtration rate (eGFR) and observed the progress after coronary artery bypass graft (CABG) treatment and complications. Findings reveal the prevalence of chronic kidney disease in patients with LMD treated with CABG.

Published
2015
Full Text
View/download PDF

47. Fractional Flow Reserve in the Diagnosis of Ischemic Heart Disease in a Patient with Coronary Artery Ectasia.

Author

Zalewska-Adamiec, Malgorzata, Kuzma, Lukasz, Bachorzewska-Gajewska, Hanna, and Dobrzycki, Slawomir

Subjects
MYOCARDIAL ischemia, CORONARY disease, CARDIAC patients, CORONARY artery disease, HEART disease diagnosis, MUCOCUTANEOUS lymph node syndrome
Abstract

Coronary artery ectasias (CAE) are diffuse dilatations of coronary artery segments with a diameter 1.5 times greater than the largest adjacent normal segment of the vessel. They are found in 0.3–5.0% of coronary angiography. Risk factors for CAE include atherosclerosis, previous percutaneous coronary interventions, arterial inflammation and connective tissue diseases. The diagnosis of CEA in a patient is a considerable diagnostic and therapeutic problem due to the unfavorable prognosis and the lack of guidelines. We present a case of a 69-year-old male patient with a history of retrosternal pain admitted to the clinic for the diagnosis of coronary artery disease. In coronary angiography, numerous ectases of the main coronary arteries and atherosclerotic lesions causing border stenosis of the left anterior descending (LAD), diagonal (2D) and marginal branch (OM). The heart team decided to assess the significance of the changes with the fractional flow reserve (FFR). The FFR was performed and haemodynamically insignificant stenoses of the ectatically dilated coronary arteries were found. The patient was qualified for conservative treatment. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

48. Pharmacologic Treatment in Dialysis Patients Hospitalized for Cardiovascular Reasons: Do We Follow the Guidelines?

Author

Tomaszuk-Kazberuk, Anna, Kozuch, Marcin, Malyszko, Jolanta, Bachorzewska-Gajewska, Hanna, Dobrzycki, Slawomir, and Musial, Wlodzimierz J.

Subjects
DIALYSIS (Chemistry), CHRONIC kidney failure, CARDIOVASCULAR diseases, HEART failure, DIABETES, CLOPIDOGREL, ASPIRIN, ADRENERGIC beta blockers
Abstract

Aim: The aim was to assess if the pharmacological treatment due to cardiovascular causes in dialysis patients is compliant with the European Guidelines. Methods: In total, 110 consecutive end-stage renal disease (ESRD) patients on regular dialysis were enrolled into the study. We divided the population into subgroups with coronary artery disease (CAD), chronic heart failure (CHF) and diabetes mellitus (DM). Results: We gathered information about drugs from 99 patients. The mean age was 61.8 ± 12.9 years (70% of males). There were 37 patients with CAD. Acetylsalicylic acid (ASA) was taken by 89% of the patients with CAD, clopidogrel by 25%, beta-blockers by 70%, angiotensin converting enzyme inhibitors (ACEIs) by 50%, angiotensin receptor blockers (ARBs) by 8%, and statins by 41%. Dual antiplatelet therapy was used after stent implantation (35%). There were 24 patients with CHF. Beta-blockers were taken by 71% of the patients, ACEIs by 45%, statins by 54%, and diuretics by 21% with CHF. There were 36 patients with DM. ASA was taken by 89% of the patients, clopidogrel and ticlopidine by 34%, beta-blockers were taken by 67%, ACE-inhibitors by 55%, and statins by 38% of the population with DM. The patients with DM were taking more ACEIs than those without DM ( p = 0.033). DM was associated with a statistically 21% higher odds of ACEI/ARB use, but CHF was associated with no increase in the odds of beta-blocker use and no increase in ACEI/ARB use. Conclusions: Dialysis patients with cardiovascular diseases are given less cardioprotective drugs such as ASA, beta-blockers, ACEIs, ARBs, and statins than they should be given according to the guidelines. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results